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Progress of inflammation depends on the balance between two biological mechanisms:
pro-inflammatory and pro-resolving processes. Many extracellular and intracellular
molecular components including cytokines, growth factors, steroids, neurotransmitters,
and lipidergic mediators and their receptors contribute to the two processes, generated
from cellular participants during inflammation. Fatty acid-derived mediators are crucial
in directing the inflammatory phase and orchestrating heterogeneous reactions of
participants such as inflamed cells, innate immune cells, vascular components,
innervating neurons, etc. As well as activating specific types of receptor molecules,
lipidergic mediators can actively control the functions of various ion channels via direct
binding and/or signal transduction, thereby altering cellular functions. Lipid mediators
can be divided into two classes based on which of the two processes they promote:
pro-inflammatory, which includes prostaglandins and leukotrienes, and pro-resolving,
which includes lipoxins, resolvins, and maresins. The research on the modulations
of neuronal ion channels regarding the actions of the pro-inflammatory class has
begun relatively earlier while the focus is currently expanding to cover the ion channel
interaction with pro-resolvents. As a result, knowledge of inhibitory mechanisms by the
pro-resolvents, historically seldom found for other known endogenous modulators or
pro-inflammatory mediators, is accumulating particularly upon sensory neuronal cation
channels. Diverse mechanistic explanations at molecular levels are being proposed and
refined. Here we overviewed the interactions of lipidergic pro-resolvents with neuronal ion
channels and outcomes from the interactions, focusing on transient receptor potential
(TRP) ion channels. We also discuss unanswered hypotheses and perspectives regarding
their interactions.
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INTRODUCTION
Inflammation is a protective mechanism of the body against physical/chemical injury, or infection.
The inflammatory reaction is associated with functional changes in diverse tissues and cell types.
In the past, the progression of inflammation from its initiation through termination was believed
to be dependent only on pro-inflammatory mechanisms on the molecular and cellular levels. That
is, when pro-inflammatory mediators are upregulated, the inflammatory response may last or even
Choi and Hwang Ion Channel Modulation by Pro-Resolvents
deteriorate because of activations of the cellular players and their
signal transduction. Conversely, when those are downregulated,
the inflammatory response may passively subside. This indicates
that pro-inflammatory mediators, secreted in response to insults,
stimulate the participant cells and tissues to become or remain
inflamed. In the absence of such stimulation, however, the cells
and tissues passively recover from the inflamed state. In the
early 2000’s, this hypothesis began to be revised (Serhan, 2002).
Resolution became to be viewed as an active, rather than a
passive, process that is accelerated by endogenous pro-resolving
agents. Accordingly, when the aim is to fight with pathologic
inflammation, the promotion of pro-resolving processes can be
hypothesized as an important goal as well as the suppression
of the pro-inflammatory processes. To understand the details of
this resolution paradigm on the cellular and molecular levels, the
identities and functions of the pro-resolving molecules (hereafter
referred to as pro-resolvents) have been intensely studied in
recent years (Serhan et al., 2015). Among heterogeneous pro-
resolving substances including peptides, nucleosides, steroids,
and neurotransmitters, here we focus on fatty acid-derived
ones. To date, about 30 pro-resolvents have been found in
endogenous fatty acid pools in inflamed exudates. Most of
these are metabolites of n−3 fatty acids, including E-series
resolvins (RvEs), D-series resolvins (RvDs), maresins (MaRs),
and neuroprotectin (NPD1).
Changes in cellular functions upon exposure to pro-
resolvents are an important aspect of the resolution paradigm.
A critical parameter driving these changes is ionic transport.
Fluctuations in ion (e.g., Ca2+) concentrations can significantly
affect intracellular signal transduction in many cell types.
Moreover, ionic flux is essential for controlling neuronal
excitability. Therefore, pro-resolvent interactions with cellular
ion-permeating channels, if any, might be an important node
for altering the inflammatory phase of cells. In fact, two axial
mechanisms regarding such interactions have emerged. One
involves ion channel modulation related to sensory neuronal
excitability and the other involves that in mucus secreting
pathways in the airway (Karp et al., 2004; Ji et al., 2011;
Yoo et al., 2013; Lim et al., 2015). The molecular details of
these two mechanisms have been investigated in the context
of inflammatory pain sensation and cystic fibrosis, respectively.
These studies have also suggested potential outcomes from
the interactions between pro-resolvents and ion channels. Of
these two mechanisms, we focus on the modulation of sensory
neuronal ion channels and discuss further derived hypotheses for
related disease progress and future perspectives.
FATTY ACID-DERIVED PRO-RESOLVENTS
Fatty acid metabolites are produced from immune cells including
monocytes/macrophages, injured tissue, and the vascular
endothelium during inflammation. After extracellular diffusion,
these substances can be further processed biosynthetically
to become final regulatory mediators which in turn interact
with their partner receptor molecules. These interactions drive
alterations in cellular function. These lipidergic components
can be divided into two categories according to their regulatory
directions in the inflammatory phases: pro-inflammatory
and pro-resolving classes (Serhan et al., 2008; Ji et al., 2011).
Although, a few exceptions exist, substances derived from n−6
fatty acids (e.g., prostaglandins and leukotrienes) generally
serve pro-inflammatory roles. By contrast, pro-resolvents
predominantly include n−3 derivatives.
Notable exceptions are lipoxin species, which are metabolites
of n−6 arachidonic acid that exhibit pro-resolving activity.
Among the lipidergic pro-resolvents, lipoxins were the first to
have their chemical structures characterized and their biological
actions identified (Serhan et al., 1984). Lipoxin was also the
first lipidergic pro-resolvent to be studied in terms of an ion
channel-associated action. In 1992, around which the curiosity
regarding lipid-ion channel interaction was increasing due to
the findings that some eicosanoids were shown to activate
K+ channels (Buttner et al., 1989; Kim and Clapham, 1989),
lipoxin A4 was demonstrated to excite dorsal root ganglionic
sensory neurons as measured by surrogate outputs of increased
bronchus contraction and neuropeptide secretion (Meini et al.,
1992). Blockage and desensitization of the vanilloid subtype
transient receptor ion channel (TRPV1) each prevented this
effect, although it was not electrophysiologically confirmed,
implicating that TRPV1 activity may be enhanced by lipoxin
A4 exposure. Lipoxin A4 did not exhibit competitive binding
with a TRPV1 agonist to the natural protein in the neuronal
membrane. However, early binding assays were not perfectly
reliable as it was later shown that TRPV1 protein was not actually
used in this assay (Meini et al., 1992). Thus it remains elusive
whether lipoxin A4 directly binds to this ion channel or indirectly
modulates its activity via signal transduction events to exert
this excitatory effect. It was considered unlikely that this n−6
derived lipoxin A4 resulted in neuronal excitation, which possibly
conflicts with other known resolution mechanisms by which
excitatory features are believed to be down-regulated. In contrast,
n−3metabolites, which constitute the majority of pro-resolvents,
have commonly been shown to suppress TRP channel activities,
eventually interfering with neuronal excitation, as described
below.
Although, this review will not focus on this topic, the
effects of lipoxins on ionic conductance have been studied
more often in the context of airway fluid balance than in
neuronal excitability (Karp et al., 2004). Lipoxins have been
shown to promote the activity and/or expression of many
different types of ion channels including epithelial Na+ channels,
cystic fibrosis transmembrane conductance regulators, ATP-
sensitive K+ channels, Ca2+-activated anion channels, pannexin
1 hemichannels, and canonical subtype of TRP channels
(TRPCs). These effects lead to beneficial outcomes with respect
to fluid secretion in the airway (Pang et al., 2011; Verriere et al.,
2012; Buchanan et al., 2013; Wang et al., 2013; Yang et al., 2013;
Al-Alawi et al., 2014; Higgins et al., 2014, 2015; Qi et al., 2015).
Recent studies showing similarly beneficial effects from treatment
of other n−3 type pro-resolvents have also emerged in the airway
field (Hiram et al., 2014; Wang et al., 2014; Colby et al., 2016).
More than a decade after the discovery of lipoxins, n−3 type
lipids began to be added in the list of pro-resolvents (Serhan
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et al., 2000). The n−3 fatty acid-derived pro-resolvents include
D-series and E-series resolvins, their isomers, neuroprotectin
D1, and maresins (Yoo et al., 2013). Variant intermediates are
first produced from source lipids [e.g., n−3 docosahexaenoic
acid (DHA) or eicosapentaenoic acid (EPA)] via pre-oxygenating
processes by cytochrome P450, aspirin-triggered cyclooxygenase,
or 12- or 15- lipoxygenases (LOXs). Next, 5-LOX generates
the final forms of all these pro-resolvents. Each enzymatic
step can occur in different types of participant cells including
monocytes/macrophages, epithelial cells, and platelets, through
intercellular diffusions of the intermediates, which is called
transcellular biosynthesis (Yoo et al., 2013). Although, this
process likely starts at the same time as the production of
pro-inflammatory mediators such as various prostaglandins, the
tissue levels of pro-resolvents seem to peak hours to days later,
which may reflect the time needed for de novo transcription of
the enzymes that produce pro-resolvents. Therefore, this time lag
contributes to the duration of the inflammatory response.
The activation of specific G-protein coupled receptors (GPRs)
and the resultant changes in cellular function explain the
molecular mechanism for many of the actions of pro-resolvents
on innate immune cells and inflamed tissues. For example,
RvE1 (E designates the precursor lipid, EPA) activates the
GPR, chemR23, and antagonizes the type 1 leukotriene B4
receptor (BLT1). RvD1 (D designates DHA) activates GPR32
and lipoxin A4/Annexin-A1 receptor/formyl-peptide receptor
2 (ALX/FPR2). RvD5 has also been shown to activate GPR32.
RvD2 activates GPR18 (Lim et al., 2015). It is unclear
whether other pro-resolvents also utilize GPR signaling. The
cellular outcomes of these molecular actions are variable but
commonly contribute to resolution: e.g., decreased production
and secretion of pro-inflammatory mediators from immune
cells and tissues, disturbance of recruitment and function of
the polymorphonuclear neutrophils, increased recruitment of
monocytes/macrophage; enhanced non-phlogistic phagocytosis
of innate immune cells, and increased secretion of peptidergic
pro-resolvents such as interleukin-10 from those cells (Yoo et al.,
2013).
After accumulation of the efficacy indices and mechanistic
information about the actions of pro-resolvents in the
immunology field, scientific interest extended to include
the relation with neuronal ion channels. This interest took 10
years to develop, longer than the period that it took from lipoxin
finding to its historical approach targeting TRPV1 (Xu et al.,
2010). It may be partly attributed to the limited availability of
substances for the academic field to study. Most of the results
have been produced from six pro-resolvents and four sensory
neuronal TRP ion channels, which will be introduced, following
a brief overview of the tradition of TRP channel-lipid interaction
studies.
TRP-LIPID INTERACTIONS
Mammals, including humans, express 28 or 29 TRP ion channel
subtypes. Different from other six-transmembrane channels,
most of which serve as voltage-gated channels, TRPs are only
weakly sensitive to changes in the membrane voltage and play
heterogeneous roles. In response to stimuli specific for each
TRP, e.g., physical stimuli such as temperatures and mechanical
forces, binding of secondmessengers, enzymatic modifications of
the protein, and endogenous chemical activators, TRP channels
open and allow predominantly Ca2+ and Na+ to permeate. This
process leads to the depolarization of excitable cells or to the
promotion of various Ca2+-mediated signaling processes in both
excitable and non-excitable cells. With respect to the chemical
binding, few cases of inhibitory modulation of TRP activity have
been found but activation and potentiation constitute majority of
reactions (Yoo et al., 2014).
Excluding the lipoxin experiment with native TRPV1
mentioned above owing to the lack of direct measurement of
channel activity, the tradition of lipid interaction studies in the
TRP field began in the late 1990s (Chyb et al., 1999; Zygmunt
et al., 1999; Hwang et al., 2000). As soon as n−6 polyunsaturated
fatty acids were reported to activate Drosophila TRP channels
(Chyb et al., 1999), anandamide, hydroperoxyeicosatetraenoic
acids (HPETEs), and leukotrienes, all of which are also n−6 fatty
acid derivatives, were identified as TRPV1 activators (Zygmunt
et al., 1999; Hwang et al., 2000) Since then, information on lipid
activators has been expanded dramatically (Choi et al., 2014; Lim
et al., 2015). The activities of TRPC and melastatin type TRP
(TRPM) species are affected by the binding of second messengers
such as diacylglycerol or its precursor, phosphatidylinositol 4,5-
bisphosphate. Ankyrin type 1 TRP (TRPA1) is highly responsive
to a broad range of lipid peroxides via a unique binding mode
whereby peroxygenated lipids covalently bind to its cytosolic
N-terminal nucleophilic amino acid residues. TRPVs tend to
be activated by hydroperoxy- or epoxy-eicosanoids. Recent
structural approaches have identified a putative lipid binding
site in the intracellular regions of TRPV1 protein as described
below. Most of those lipids can activate only their specific TRP
channel and can also synergistically potentiate its activity in
the presence of a stimulus with a different quality. These lipid
activators are generated by various cells, even cells expressing
TRPs. These molecules appear to behave in an autocrine and
paracrine manner. TRP activations by these lipids in neurons
mostly promote their excitability.
MODULATION OF SENSORY TRP
ACTIVITIES BY PRO-RESOLVENTS
Several TRPs serve as molecular sensors for environmental
changes, expressed particularly highly in the skin-innervating
terminals of somatosensory nerve C-fibers and Aδ fibers. Among
28 human subtypes, 6 members, which are TRPA1, TRPV1-4,
and TRPM8, play this role and are collectively called sensory
TRPs. These sensory TRP channels are all polymodal to some
extent, which might be an evolutional strategy for enabling
sensory neurons to monitor a variety of environmental changes.
All 6 of these TRPs are responsive to a particular range of
temperatures and 3 of them are sensitive to different qualities
of mechanical stretching (Hwang and Oh, 2007). Regarding
chemical sensitivities, a surprisingly large number of natural
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pungent substances, toxins, and different kinds of endogenous
lipids, have been shown to activate sensory TRPs. In specialized
sensory organs in the vision, olfaction, and gestation systems,
the majority of sensor molecules are specific types of GPRs
and TRP channels predominantly function as downstream
effectors driving depolarization. In contrast, sensory TRPs seem
to be the major receptors to detect environmental risks in the
somatosensory system. This setup likely benefits from the high
degree of polymodality of TRPs. Rather than with pleasant
or explorative quality, perception by our brain resulting from
TRP activation is with a nociceptive one: pain. This attribute
frequently places TRP modulation as a desirable goal at the
viewpoint of analgesia which can be rephrased as resolution
of pain (Lim et al., 2015). Many studies of the interactions of
TRPs with fatty acid-derived pro-resolvents have adhered to
this angle. Six pro-resolvents have been investigated in terms
of their actions on five different neuronal ion channels, four of
which are TRPs. All the pro-resolvents negatively modulated the
ion channel activities, indicating that these lipids are potential
analgesics (Table 1).
TRPA1 Modulations by D-Series Resolvins
and MaR1
As detailed above, the TRPA1 ion channel is expressed in only
a subpopulation of pain-mediating nociceptors. Some types of
physical and chemical insults that are potentially harmful to
the body can affect the structure of TRPA1 protein, leading
to allosteric opening of this channel. Thus TRPA1 is often
called a “damage-sensing ion channel.” TRPA1 is particularly
sensitive to noxiously cold temperatures (<17◦C; Story et al.,
2003; Obata et al., 2005; Kwan et al., 2006; Karashima et al., 2009;
Del Camino et al., 2010; Chen et al., 2011), harsh mechanical
deformations (Petrus et al., 2007; Kerstein et al., 2009), and
the binding of environmental or endogenously generated toxic
substances including diverse lipid peroxides, reactive chemicals,
TABLE 1 | List of neuronal ion channels that are modulated by lipidergic
pro-resolvents.
Ion channel Lipidergic pro-resolvents
TRPA1 Resolvin D1 (Bang et al., 2010),
Resolvin D2 (Park et al., 2011b),
Maresin 1 (Serhan et al., 2012)
TRPV1 Resolvin D2 (Park et al., 2011b),
Resolvin E1 (Xu et al., 2010; Park
et al., 2011b), Neuroprotectin D1
(Park et al., 2011a), Maresin 1
(Serhan et al., 2012; Park, 2015)
TRPV3 AT-resolvin D1 (Bang et al., 2012a),
Resolvin D1 (Bang et al., 2010)
TRPV4 Resolvin D1 (Bang et al., 2010)
NMDA receptor Resolvin E1 (Xu et al., 2010), Resolvin
D1 (Quan-Xin et al., 2012)
and pollutants (Bang and Hwang, 2009; Kim and Hwang, 2013).
In response to these stimuli, TRPA1 opens and depolarizes the
nociceptors. Hardly shown in activation mechanisms for other
ion channels, covalent reactions with specific nucleophilic amino
acids in the cytosolic N-terminus of TRPA1 with α,β-unsaturated
carbon-containing substances seem to underlie the ligand-
mediated gating of TRPA1 (Hinman et al., 2006; Macpherson
et al., 2007; Andersson et al., 2008; Bang and Hwang, 2009).
In addition, TRPA1 also acts as a final effector in intracellular
signal transduction for inflammatory mediators such as nerve
growth factor (NGF) and bradykinin, indicating that TRPA1 is
critical for inflammatory pain sensation (Bandell et al., 2004;
Bautista et al., 2006; Kwan et al., 2006; Petrus et al., 2007; Cenac,
2013). Due to this polymodality and the distinctively limited
number of TRPA1-positive neurons, these neurons are frequently
subcategorized into polymodal nociceptors. The identification
of a mechanism for inhibiting TRPA1 activity, would greatly
contribute to the resolution of pain states (Baraldi et al., 2010).
Of particular note, pro-resolvents seem to have a central
role for endogenous inhibition of TRPA1. For instance, resolvin
D1 (RvD1) strongly blocks TRPA1 activity (Bang et al., 2010).
This channel blocking potency indeed extrapolates to the
in vivo level by showing that TRPA1 agonist-induced chemical
pain were attenuated by RvD1 administration. TRPA1 also
takes part in the mechanosensory mechanisms, and RvD1
was shown to prevent mechanical hypersenstivity in complete
Freund’s adjuvant (CFA)-inflamed animals. Since RvD1 is locally
confinedwhen injected and outcomes weremeasured at relatively
acute time points, the pain relief observed in vivo appears to
be mediated in the absence of intercellular actions such as
recruitment or activation of innate immune cells.
RvD2 also inhibits TRPA1 activity (Park et al., 2011b).
G-protein-mediated signal transduction seems to intervene the
molecular mechanism of this process while such an explanation
is unlikely for RvD1: the inhibitory action of RvD2 was shown
to be prevented by the uncouplers for Gαi-cycling, pertussis
toxin, and GDPβS. The specific GPR that initiates the signal
has yet to be identified. On the other hand, specific agonists for
ALX/FPR2, the GPR on which RvD1 acts, such as cathelicidin
LL-37 and Trp-Lys-Tyr-Met-Val-Met (WKYMVM) are inert to
TRPA1 activation or inhibition (Bang et al., 2010). To confirm
their mechanism of action, the different modes for these related
substances for the same target protein may need to be revisited
(Figure 1). Subtle structural difference (e.g., differences in the
location of one hydroxyl moiety and in the cis-trans nature of
carbon links) may determine the receptor binding specificity.
With respect to behavioral outcomes, no significant discrepancy
was observed. TRPA1-mediated mechanical phenotype was
greatly improved under inflamed conditions (Park et al., 2011b).
MaR1 is a recently identified pro-resolvent that has been
demonstrated to elicit somewhat contradictory outcomes.
In vitro electrophysiological measurements indicated
that TRPA1 activity is not affected by the presence of
MaR1 (Serhan et al., 2012). However, vincristine-induced
in vivo mechanical hypersensitivity, to which TRPA1 is
known to contribute, was significantly alleviated by MaR1
treatment. Without direct TRPA1 involvement, MaR1 may act
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FIGURE 1 | Molecular modes of action by which pro-resolvents inhibit TRP channels. Dotted lines indicate that other unknown signaling components may
take part during the pathways.
downstream or upstream of TRPA1 mediation in pathological
processes.
TRPV1: An Important Node for Various
Resolving Actions
With a greater polymodality than that of TRPA1, TRPV1 serves
as a central pain receptor in the body. Potentially damaging
heat (>42◦C), acidosis, abnormal hypertonicity, endogenous
lipidergic pro-inflammatory messengers such as leukotrienes,
and natural pungent compounds such as capsaicin and tarantula
toxin evoke pain via direct structural challenges to TRPV1
protein, culminating in its electrical activation (Caterina et al.,
1997, 2000; Tominaga et al., 1998; Davis et al., 2000; Hwang et al.,
2000; Siemens et al., 2006; Vriens et al., 2009; Nishihara et al.,
2011). Furthermore, major pro-inflammatory mediators such
as bradykinin, prostaglandin, and NGF utilize TRPV1 as their
downstream effector, thereby causing pathologic exacerbation of
pain and inflammation (Basbaum et al., 2009). These findings
have implicated TRPV1 as the forefront node between painful
insult and human and mammalian perception of$ it (Hwang
and Oh, 2007). While such nodal actions are well-defined in
the periphery of the sensory neurons, evidence is currently
expanding for its contribution in the central terminals and
even in spinal interneurons to the boosting pain circuit, which
suggests that its different nodal roles exist in the central
synapses (Choi et al., 2016). Therefore, TRPV1 may also be
a critical pain resolving node because the extensive scale of
pain pathologies could be controlled if TRPV1 activity could be
tuned.
In the same way for TRPA1 inhibition, RvD2 suppresses
TRPV1 activity. Through unknown GPR activation by RvD2,
intracellular Gαi-coupled signaling leads to decreased TRPV1
activity. Of all the pro-resolvents whose ability to inhibit
TRP has been studied, RvD2 exhibits the strongest potency
(IC50 ∼100 pM). Predictably, acute pain induced by capsaicin
and inflammatory heat hyperalgesia, which are the in vivo
modalities that TRPV1 predominantly covers, were both blunted
by RvD2 treatment (Park et al., 2011b).
Similarly, RvE1 and MaR1 have been found to inhibit TRPV1
activity and TRPV1-mediated pain behavior, but did not affect
modalities involving TRPA1 (Xu et al., 2010; Park et al., 2011b;
Serhan et al., 2012; Park, 2015). Since RvE1 acts on a single GPR
(chemR23), it can be hypothesized that certain GPR signaling
pathways may be more tightly coupled to specific TRP subtypes.
In fact, coexpression of chemR23 and TRPV1 has been confirmed
in a subset of nociceptors (Xu et al., 2010).
Neuroprotectin D1 (also called protectin D1 or NPD1),
another D-series pro-resolving lipid, has also been shown to
inhibit TRPV1 albeit one third of the potency of RvD2 (Park
et al., 2011a). A Gαi protein-coupled indirect mechanism was
again suggested to underlie this inhibitory action, although
the specific GPR involved is not known. Other signaling
components that can amplify TRPV1activity may also be affected
by NPD1, for example, protein kinase A (PKA) and extracellular
signal–regulated kinase (ERK; Park et al., 2011a). Moreover,
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TNF-α-mediated spinal synaptic transmission was attenuated
and the associated behavioral phenotypes were extrapolated in a
manner partly dependent on TRPV1 inhibition. Recently, NPD1
treatment also exhibited beneficial effects on neuropathic pain in
an animal study (Xu et al., 2013).
TRPV3 Modulation by D-Series Resolvins
Several aspects may make one hesitate to conclude that TRPV3
is a nociceptive component. For example, TRPV3 begins to
open in response to relatively mild heat radiation that results
in innocuously warm temperatures (>33◦C), whereas the
temperature threshold for TRPV1 activation is close to the range
reported to actually cause pain perception in vivo (Caterina
et al., 2000; Moqrich et al., 2005). The main expresser cells
are not sensory neurons but non-excitable basal keratinocytes
in the epidermis (Peier et al., 2002). The presence of TRPV1
seems to be sufficient to monitor external noxious temperatures
(Peier et al., 2002; Smith et al., 2002; Xu et al., 2002, 2006).
Although, the precise intercellular circuitry involved in TRPV3-
mediated somatosensory signaling has yet to be fully unraveled,
pharmacological, and genetic studies have yielded some insights.
Industrial drug developments targeting TRPV3 have shown that
synthetic TRPV3 blockers commonly exhibit painkilling efficacy
in inflammatory and neuropathic pain (Facer et al., 2007; Bevan
et al., 2008; Broad et al., 2009; Khairatkar Joshi et al., 2010; Reilly
and Kym, 2011). More importantly, TRPV3-knockout animals
have shown significant tolerance to painful heat (Moqrich et al.,
2005; Huang et al., 2008; Miyamoto et al., 2011). Thus, TRPV3
participates in nociception of noxiously high temperatures albeit
to a lesser extent than TRPV1, and keratinocytes may contribute
to thermosensation possibly by transmitting their depolarization
signals to neighboring nociceptor neurons.
Consistently, both resolvins that modulate TRPV3 activity
exert painkilling effects. Aspirin-triggered RvD1 (AT-RvD1 or
17(R)-RvD1) has been shown to specifically block TRPV3. The
in vivo administration of this compound has been shown to
mitigate heat pain, a TRPV3-mediated sensory modality, but
not mechanical pain under inflammatory conditions (Bang
et al., 2012a). RvD1, which is relatively promiscuous in TRP
interactions (as mentioned for TRPA1 above and TRPV4 below),
has also been shown to inhibit TRPV3 channel opening and
TRPV3-mediated pain (Bang et al., 2010). As shown in TRPA1
findings, AT-RvD1 and RvD1 unlikely utilize G-protein-coupled
signaling for TRPV3 inhibition because these effects were
resistant to treatment of the Gβγ inhibitor gallein and to
treatment of the GPR agonists LL37 andWKYMVM (Bang et al.,
2010, 2012a). Other indirect mechanisms such as participation
of innate immune cells were also excluded by localizing RvDs to
limited regions and times and showing that the effective doses
were different than those for leukocytes (Krishnamoorthy et al.,
2010).
TRPV4 Modulations by RvD1
Albeit to a lesser extent than TRPV1 and TRPA1, TRPV4 is
also a polymodal sensor ion channel. Elevated temperatures
(>27–34◦C), mechanical stretching caused by pressure or
swelling, and endogenous pro-inflammatory mediators
such as epoxyeicosatrienoic acids (EETs) and dimethylallyl
pyrophosphate are able to activate TRPV4 (Liedtke et al.,
2000; Strotmann et al., 2000; Watanabe et al., 2003; Levine and
Alessandri-Haber, 2007; Bang et al., 2012b). This activation is
believed to lead to depolarization of the primary nociceptors,
ultimately resulting in pain perception via the ascending
transmission of this signal. While changes in thermonociceptive
behaviors affected by TRPV4 knockout were significant but
limited compared to phenotypes reported from genetic ablation
of TRPV1 or TRPV3 (Todaka et al., 2004; Lee et al., 2005), the
mechanosensory modalities that involve TRPV4 appear to be
remarkable. Many types of inflammation caused somatosensory
mechanical hyperalgesia or visceral mechanical hyperalgesia via
TRPV4 activation (Alessandri-Haber et al., 2006; Chen et al.,
2007; Grant et al., 2007; Brierley et al., 2008; Cenac et al., 2008).
In the context of GPR-mediated inflammatory pain signaling,
activation of protease-activated receptor 2 (PAR2, also known
as GPR11) by trypsin or thrombin secreted from tissues is
linked to TRPV4, which functions as its downstream effector for
nociceptor neuronal firing (Grant et al., 2007). Histamine and
serotonin also seem to contribute to GPR cascade, culminating
in TRPV4 potentiation, thereby exacerbating visceral pain
(Brierley et al., 2008; Cenac et al., 2008, 2010). In two different
models of neuropathic pain, a chronic constriction injury model
and a taxol-induced neuropathy model, TRPV4 contributed to
increased mechanical pain (Alessandri-Haber et al., 2004; Zhang
et al., 2008).
RvD1 is the only resolvin to date found to inhibit TRPV4.
The Levine lab established an in vivo method for indexing
TRPV4-specific somatosensory mechanical pain phenotypes. In
this approach, hypotonic stimulation is applied locally to a rat
paw when the paw is pre-primed with an inflammatory mediator
prostaglandin E2 (Alessandri-Haber et al., 2003, 2006; Chen et al.,
2007). The Hwang lab has reproduced this model with mice
(Bang et al., 2010, 2012b). RvD1 was shown to be effective at
alleviating TRPV4-specific inflammatory mechanical pain (Bang
et al., 2010). Heat hyperalgesia in CFA-induced inflammation was
also blunted by in vivo treatment of RvD1. Of the four heat sensor
TRPs (TRPV1-4), TRPV3 and TRPV4 have been identified as
molecular targets of RvD1. However, it remains unclear whether
TRPV3 or TRPV4 predominates over the RvD1 effect on the
thermal phenotype.
Using the same experimental approach described above for
TRPA1 and TRPV3, an indirect ALX/FPR2-mediated GPR
pathway has been excluded from the potential molecular
interacting mechanism underlying these results. Although, it is
unclear without binding assay, modulation via direct contact
can be considered from what was recently hypothesized.
It is suggested that chemical interactions between the lipid
components of the bilayer membrane and the embedded regions
of ion channel proteins are important for appropriate ion channel
response and gating (Bavi et al., 2016). For ion channels with six
transmembrane domains (which include TRP channel), one of
the most critical regions in this regard is the intracellular linker
between transmembrane domain (TM) 4 and TM5. For voltage-
gated channels, this linker is crucial for allosteric conversion
of movement of the TM4 voltage sensor upon depolarizing
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stimulation into gating of the pore located between TM5 and
TM6. According to recent structural approaches, the same linker
of TRPV1 protein seems to bind to a lipidergic component and
may also be responsible for transducing this binding energy to the
pore region (Cao et al., 2013; Liao et al., 2013). The corresponding
region of a bacterial mechanosensitive ion channel has been
shown to be important since membrane stretching appears to
alter binding between the linker and the bilayer lipids, resulting
in pore opening (Bavi et al., 2016). Therefore, it is hypothesizable
that the structure of this linker region is vulnerable (or sensitive)
to external physical or chemical challenges (e.g., voltage increases
that outwardly tilt the TM4 helix, membrane stretching that
dysregulates bilayer contacts, lipidergic ligands that substitute a
bilayer component, etc.), subsequently affecting the condition of
the pore. In its closed states the linker region of TRPV1is pre-
occupied by an endogenous lipid that has not yet been identified
(Cao et al., 2013). In the structure of TRPV4, the closest homolog
of TRPV1 (Teng et al., 2015), the lipid activators such as EETs
may compete with the pre-occupying lipid, as predicted from
capsaicin or HPETE interaction with TRPV1 (Hwang et al., 2000;
Jordt and Julius, 2002). Conversely, RvD1 may more strongly
stabilize the resting state than the pre-occupying endogenous
one when located in the same place (Figure 1). When previous
observations of lipidergic activators are considered together, it is
possible that different double-bond locations of n−3 and n−6
derivatives may first direct stabilizing and destabilizing effects,
and that the carbon lengths and locations of hydroxyl moieties
that likely determine optimal occupation and hydrogen bond
potential may define TRP specificity (Chyb et al., 1999; Hwang
et al., 2000; Hu et al., 2006; Andersson et al., 2007; Komatsu et al.,
2012; Motter and Ahern, 2012). Future experimental evidence is
necessary to prove this hypothesis.
N-Methyl-D-Aspartic acid (NMDA)
Receptor Modulation by Resolvins
Nociceptor populations among primary sensory neurons
propagate peripheral pathologic signals, including those
originating from inflammation, to the central nervous
system. Moreover, these neurons actively contribute to
pro-inflammatory processes via neurogenic inflammation
mechanisms, by interactively exchanging various intercellular
mediators with innervating tissues. These are important steps
in the development of chronic inflammatory pain. In terms of
pain relief, the TRPs mentioned above are essentially focused on
when resolution mechanisms are examined, since the activation
of these ion channels explains the outset of nociceptor excitation
and pathologic hyperactivity, which often exacerbate neurogenic
inflammation. The actions of pro-resolving lipids through
these sensory TRP modulations all seem to converge on pain
alleviation.
Postsynaptic dorsal horn neurons translate and relay signals
received from the synaptic inputs of the central terminals of
nociceptor neurons in the spinal cord (Choi et al., 2016). This
synaptic transmission is the next gate to the development of
persistent pain, which is determined by whether this spinal
synapse is strengthened by a barrage of peripheral input.
Postsynaptic NMDA receptor ion channels play a key role in
this process (Lim et al., 2015). Pro-resolvents also down-regulate
postsynaptic NMDA function in this central postsynapse, but
partly in a different manner than for TRP channel modulations.
The same GPR, chemR23, is involved in RvE1 action, but
the dorsal horn-specific ERK phosphorylation cascade, which
promotes NMDA potentiation, was mainly suppressed (Xu et al.,
2010). A later RvD1 experiment has demonstrated another aspect
of functional down-regulation of NMDA by showing that RvD1
treatment decreased phosphorylation of two NMDA subunits,
NR1 and NR2B, in a model of pancreatitis-induced allodynia, but
without confirming the knowledge of related GPRs (Quan-Xin
et al., 2012).
Upon RvE1 exposure, presynaptic ERK phosphorylation has
also been shown to be suppressed. In addition, the frequency
of spontaneous excitatory postsynaptic potentials, which reflects
not only postsynaptic function but also the extent of presynaptic
glutamate release, was also decreased. This finding may also
explain the RvE1-mediated suppression of TRPV1-independent
presynaptic TNF-α signals (Xu et al., 2010). The mechanistic
difference that occurs in the central synaptic region is conceivable
while TRP channel modulation by pro-resolvents, which is
probably more important in the periphery, is presumed to
be mediated via direct binding or a rapid signal transduction
through tightly coupled G-protein cycling.
PERSPECTIVES AND CONCLUSIONS
Here we reviewed the effects of various pro-resolving lipids
on the functions of four sensory TRP channels and NMDA
receptors that convey nociceptive signals. These pro-resolvents
commonly showed strong inhibitory actions on these ion
channels, leading to a final outcome of pain resolution. It is
perhaps surprising that a group of endogenous lipid derivatives
from common precursors can contribute to the resolution
of two different pathologic processes, pain and inflammation,
via differential cellular targets and biological mechanisms.
Immunology studies continue to confirm that the absence of
adverse effects from in vivo treatment of these substances.
Based on current efficacy and safety information, translational
applications of these substances to some specific diseases are
eagerly anticipated. Before this promise can be realized, it
would be advantageous to establish proof of concept to clarify
the relevant molecular mechanisms. The most ambiguous ones
to date are the binding mode by which these pro-resolving
lipids interact with channel proteins and the mechanisms
how they initiate GPR-mediated signal transduction. Although,
one putative lipid-interacting site has been predicted, it has
not yet been established whether resolvins modify channel
activity through this site. When GPR coupled, it has not been
completely answered which GPR predominantly drives the
effect and which intracellular signal deactivates the channel.
Most studies have focused on the sensory circuit. TRPV
channels are involved in plastic changes in other brain synapses
(Shibasaki et al., 2007; Gibson et al., 2008). NMDA receptors
are essential ion channels for synaptic strengthening throughout
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the whole brain. In addition to ion channel interaction in
excitable neurons, changes in microglial function similar to
those in monocyte/macrophage function may also be important
checkpoints as once shown (Xu et al., 2010). Pro-resolvents
are endogenously generated. Although, neuronal ion channels
are strongly regulated by extraneous treatment, it remains to
be elucidated which the major sources are among components
in the nervous system and how similarly their transcellular
biosyntheses occur as previously reported in the immune
system.
Lessons from studies of the airway or other tissues may help
to frame a different paradigm. In the airway research field,
rather than channel activation or inhibition, changes in the
expression of an ion channel are a more important axis to
define the effect of a pro-resolvent, which have received little
attention in the neuroscience field. The activity of Ca2+-activated
anion channels is increased upon pro-resolvent treatment in
the airway epithelium (Verriere et al., 2012). These channels
are considered to be an important temperature sensor and
depolarizer in nociceptor neurons (Cho et al., 2012). However,
this interaction has yet to be tested for neuronal outcomes. Future
studies for all these questions will help determine whether these
pro-resolvents (or future synthetic analogs thereof) will have
clinical applications, how firmly the proof of concept needs to be
established, and which pieces are missing in order to fully explain
the molecular puzzle of ion channel interactions with lipidergic
pro-resolvents.
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